Inovio Pharma (INO) Stock Price, Quote & News

Company Profile

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline inclu...

Industry: Biotechnology

Sector: Healthcare

Phone: 267 440 4200

Website: www.inovio.com

Address:

660 West Germantown Pike, Suite 110, Plymouth Meeting, United States

BKuma29 Nov. 15 at 2:44 AM

$INO Alyeska Investment Group, L.P. with a 7.53% stake. https://d18rn0p25nwr6d.cloudfront.net/CIK-0001055726/8c95bcb5-14a5-4e0f-9ad0-f95d622b3806.pdf

0 · Reply

INOxray8 Nov. 15 at 1:45 AM

$INO TACO Caves - GNS Sues Finally. A break in the dam. A hard one. TACO (Trump Always Chickens Out) couldn’t take the heat. Breaking News Friday night, the arsonist is now gonna try to put out the fire. Hilarious, pathetic, and epic self-own. The tariffs are toast. And he’ll pray that the Supreme Court officially saves him from his own idiocy by ruling against him. Where are his shameless defenders?!??? Crickets. But the even bigger news is that GNS is suing Virtu and Citadel for massive naked short selling of their stock . Finally. Even though we are eventually heading for a Depression-level Crash, the market is now set up for a massive run into the holidays. Come Monday morning, meme stocks, gold (and the market broadly) will be mooning. Absolutely rocking. INO will ride this wave. Surf’s up! imho xx

1 · Reply

tau72 Nov. 14 at 11:08 PM

$INO Exciting time ahead. Next week and beyond will be great for INO's longtime shareholders. Till then, have a great weekend.

0 · Reply

wallstbullinfinity Nov. 14 at 11:06 PM

$INO 🧬🧬🧬🌍🌍🌍 It's a must 🧬🧬🧬🌍🌍🌍

0 · Reply

favman Nov. 14 at 11:05 PM

$INO $GNS https://ir.geniusgroup.net/news-events/press-releases/detail/214/genius-group-files-federal-securities-class-action-lawsuit

0 · Reply

CptHubes Nov. 14 at 10:42 PM

$INO probably nothing…. Long live Inovio. Bashers can kick rocks. DNA medicine can kick ass.

0 · Reply

InovioSellsStockNotDrugs Nov. 14 at 10:41 PM

$INO Dprot’s are preclinical and have no value. Inovio is only bringing this up so they have something new and shiny for you idiots to latch onto once they kill the 3107 program. You are so gullible Luis. Thank goodness you have your great TA skills to fall back on😂😂😂. You still seeing resistance at the 0 level? Any luck finding that your lost $25K? Doubtful after this week, hahahaha

0 · Reply

LuisBarajas16 Nov. 14 at 10:32 PM

$INO https://www.marketscreener.com/news/inovio-pharmaceuticals-14th-world-federation-of-hemophilia-global-forum-presentation-ce7d5fd2df81f623

1 · Reply

InovioSellsStockNotDrugs Nov. 14 at 10:20 PM

$INO

1 · Reply

BKuma29 Nov. 14 at 10:12 PM

$INO

1 · Reply

Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress

Nov 11, 2025, 8:40 AM EST - 3 days ago

INOVIO Announces Pricing of $25 Million Public Offering

Nov 10, 2025, 7:31 PM EST - 4 days ago

Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 6:09 PM EST - 4 days ago

INOVIO Announces Proposed Public Offering

Nov 10, 2025, 4:05 PM EST - 4 days ago

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Nov 3, 2025, 8:05 AM EST - 11 days ago

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Oct 31, 2025, 4:53 PM EDT - 14 days ago

INOVIO Reports Inducement Grant Under Inducement Plan

Oct 27, 2025, 8:05 AM EDT - 18 days ago

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Oct 23, 2025, 4:05 PM EDT - 22 days ago

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

Oct 21, 2025, 8:05 AM EDT - 24 days ago

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Sep 25, 2025, 8:05 AM EDT - 7 weeks ago

INOVIO to Participate in Upcoming Scientific Conferences

Sep 5, 2025, 9:37 AM EDT - 2 months ago

Inovio Pharmaceuticals, Inc. (INO) Presents At H.C. Wainwright 27th Annual Global Investment Conference (Transcript)

Aug 26, 2025, 8:05 AM EDT - 2 months ago

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

Aug 25, 2025, 8:05 AM EDT - 2 months ago

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 13, 2025, 3:26 AM EDT - 3 months ago

Inovio Pharmaceuticals, Inc. (INO) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:05 PM EDT - 3 months ago

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Aug 11, 2025, 8:05 AM EDT - 3 months ago

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Aug 4, 2025, 4:05 PM EDT - 3 months ago

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 7, 2025, 4:05 PM EDT - 4 months ago

INOVIO to Present at Upcoming Scientific Conference

Jul 1, 2025, 7:00 AM EDT - 4 months ago

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

May 13, 2025, 7:05 PM EDT - 6 months ago

Inovio Pharmaceuticals, Inc. (INO) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:05 PM EDT - 6 months ago

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 9, 2025, 7:37 PM EDT - 6 months ago

Inovio Pharmaceuticals, Inc. (INO) Citizens JMP Life Sciences Conference (Transcript)

Apr 30, 2025, 8:05 AM EDT - 7 months ago

INOVIO to Present at Upcoming Scientific and Investor Conferences

Apr 29, 2025, 8:05 AM EDT - 7 months ago

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 9, 2025, 8:05 AM EDT - 7 months ago

INOVIO to Present at Upcoming Scientific Conferences

Mar 18, 2025, 8:48 PM EDT - 8 months ago

Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 4:05 PM EDT - 8 months ago

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Mar 13, 2025, 6:15 PM EDT - 8 months ago

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

Mar 12, 2025, 12:55 PM EDT - 8 months ago

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025

Feb 12, 2025, 5:39 PM EST - 9 months ago

Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript)

Feb 12, 2025, 8:00 AM EST - 9 months ago

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications

Feb 10, 2025, 8:05 AM EST - 9 months ago

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference

Jan 29, 2025, 4:14 PM EST - 10 months ago

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 9, 2025, 8:04 AM EST - 11 months ago

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

Jan 6, 2025, 7:19 AM EST - 11 months ago

Top 3 Health Care Stocks That Could Blast Off This Month

OTLK RCKT

Dec 13, 2024, 2:10 PM EST - 1 year ago

Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet

Dec 13, 2024, 7:00 AM EST - 1 year ago

INOVIO Announces Pricing of $30 Million Public Offering

Dec 3, 2024, 8:00 AM EST - 1 year ago

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

Nov 15, 2024, 11:21 AM EST - 1 year ago

European And US Vaccine Stocks Are Under Pressure - Here's WHy

AZN BNTX GSK MRK SNY VALN

Nov 14, 2024, 7:53 PM EST - 1 year ago

Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:05 PM EST - 1 year ago

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 13, 2024, 8:00 AM EST - 1 year ago

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial

Nov 6, 2024, 8:00 AM EST - 1 year ago

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

Oct 21, 2024, 8:00 AM EDT - 1 year ago

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP

Oct 2, 2024, 4:15 PM EDT - 1 year ago

INOVIO Reports Inducement Grants Under Inducement Plan

Aug 9, 2024, 3:32 AM EDT - 1 year ago

Inovio Pharmaceuticals, Inc. (INO) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 1 year ago

INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Jul 25, 2024, 4:05 PM EDT - 1 year ago

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

Jul 25, 2024, 8:00 AM EDT - 1 year ago

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

BKuma29 Nov. 15 at 2:44 AM

$INO Alyeska Investment Group, L.P. with a 7.53% stake. https://d18rn0p25nwr6d.cloudfront.net/CIK-0001055726/8c95bcb5-14a5-4e0f-9ad0-f95d622b3806.pdf

0 · Reply

INOxray8 Nov. 15 at 1:45 AM

1 · Reply

tau72 Nov. 14 at 11:08 PM

$INO Exciting time ahead. Next week and beyond will be great for INO's longtime shareholders. Till then, have a great weekend.

0 · Reply

wallstbullinfinity Nov. 14 at 11:06 PM

$INO 🧬🧬🧬🌍🌍🌍 It's a must 🧬🧬🧬🌍🌍🌍

0 · Reply

favman Nov. 14 at 11:05 PM

$INO $GNS https://ir.geniusgroup.net/news-events/press-releases/detail/214/genius-group-files-federal-securities-class-action-lawsuit

0 · Reply

CptHubes Nov. 14 at 10:42 PM

$INO probably nothing…. Long live Inovio. Bashers can kick rocks. DNA medicine can kick ass.

0 · Reply

InovioSellsStockNotDrugs Nov. 14 at 10:41 PM

0 · Reply

LuisBarajas16 Nov. 14 at 10:32 PM

$INO https://www.marketscreener.com/news/inovio-pharmaceuticals-14th-world-federation-of-hemophilia-global-forum-presentation-ce7d5fd2df81f623

1 · Reply

InovioSellsStockNotDrugs Nov. 14 at 10:20 PM

$INO

1 · Reply

BKuma29 Nov. 14 at 10:12 PM

$INO

1 · Reply

BKuma29 Nov. 14 at 10:09 PM

$INO https://s23.q4cdn.com/479936946/files/doc_events/2025/Nov/14/World-Forum-Hemophilia-Global-Forum-2025-Nov-14-FINAL.pdf

1 · Reply

InovioSellsStockNotDrugs Nov. 14 at 9:45 PM

$INO

0 · Reply

INOVIO Nov. 14 at 9:24 PM

$INO https://www.gurufocus.com/news/3209809/ino-todays-analyst-rating-highlights-20-target-price-increase-ino-stock-news

0 · Reply

Lookingdown Nov. 14 at 9:20 PM

$INO Hot off the press 👇👇 Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers November 14, 2025 https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1662923/full

1 · Reply

InovioSellsStockNotDrugs Nov. 14 at 9:09 PM

$INO I admire your dedication LD. No matter how many times Inovio takes a dump on your doorstep, you keep coming back for more. You idiots realize they’re hitting the atm now right? Just a matter of time until new all time lows and reverse split. Tik tok

1 · Reply

Lookingdown Nov. 14 at 9:01 PM

$INO I just had to do it 🤭

1 · Reply

INOVIO Nov. 14 at 8:57 PM

$INO

0 · Reply

Stormra Nov. 14 at 8:56 PM

$INO

0 · Reply

InovioSellsStockNotDrugs Nov. 14 at 8:52 PM

$INO

0 · Reply

updownsides Nov. 14 at 8:47 PM

$INO $PGEN Riotard doesn't even know his own stock. Ino - public offering of 13,158,000 shares of its common stockto close on or about November 12, 2025. INOVIO also granted the underwriters an option for a period of 30 days to purchase up to 1,973,700 additional shares. Add them puppies to your 94.5M and what do you have.....for the time being anyways. Also I didn't include the other 2 reverse splits before the latest 12-1. Fraction of a penny is all it's worth. Precigen has never done a reverse split by the way.

2 · Reply

Lookingdown Nov. 14 at 8:42 PM

$INO 👇🔥👇😉💪💎 Check out this video, "ino-3107" https://share.google/h63AEVC0d5WiFaN1H

0 · Reply

InovioSellsStockNotDrugs Nov. 14 at 8:22 PM

$INO $PGEN learn to read Robert. He said pushing before this offering. Now it’s well over 100 mil. Look how much capital precigen is burning to commercialize. And they don’t have a shitty device to mass produce or train on. The dilution here is just starting. You are really, really bad at this. Guess your mom doesn’t like golden coral😂😂😂😂😂😂😂😂😂

1 · Reply

Market Cap	104.47M
Revenue (ttm)	220,000.00
Net Income (ttm)	-107.25M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-48,750.00%
Debt to Equity Ratio	0.00

Volume	1,487,600
Avg Vol	1,245,212
Day's Range	N/A - N/A
Shares Out	53.57M
Stochastic %K	22%
Beta	1.64
Analysts	Strong Sell
Price Target	$7.47